GLP-1 & Birth Control: What to Know

A critical interaction that is not discussed enough

The prescribing information for tirzepatide (Zepbound and Mounjaro) includes a specific warning about oral contraceptive effectiveness. Semaglutide (Wegovy and Ozempic) prescribing information mentions it as a consideration. If you rely on oral birth control pills and are considering GLP-1 treatment, this is a conversation you need to have — ideally before starting the medication.

The mechanism: delayed gastric emptying and pill absorption

GLP-1 medications slow gastric emptying — food and medications stay in the stomach longer. For most medications, this has minimal clinical significance. For oral contraceptives, however, the concern is specific: if a birth control pill is retained in the stomach longer than usual, the timing and completeness of absorption may change. Altered absorption could theoretically reduce contraceptive effectiveness.

This is not a theoretical concern with all GLP-1 medications equally. The tirzepatide prescribing information recommends that patients using oral hormonal contraceptives switch to a non-oral method or add a barrier method for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase. The semaglutide prescribing information acknowledges the potential for altered absorption but does not include the same specific 4-week recommendation — though many providers advise cautious approaches with both medications.

What the data actually shows

A dedicated drug interaction study examined the effect of tirzepatide on oral contraceptive pharmacokinetics. The study found that tirzepatide reduced the maximum concentration and total exposure of the oral contraceptive components by approximately 20-25% after the first dose. However, with continued weekly dosing, this effect diminished as the body adapted. The clinical significance of this reduced exposure — whether it actually increases pregnancy risk — has not been definitively established, which is why conservative clinical guidance errs on the side of caution.

Practical guidance by contraceptive method

• Oral contraceptive pills: The highest concern. Discuss with your provider whether to add a barrier method (condoms) for the first 4 weeks after starting GLP-1 treatment and for 4 weeks after each dose increase. Some providers recommend this for tirzepatide specifically.
• Contraceptive patch and vaginal ring: These bypass the gastrointestinal tract entirely and are not affected by delayed gastric emptying. They are generally considered safe to continue without additional precautions.
• IUDs (hormonal and copper): Not affected by GLP-1 medications. No additional precautions needed.
• Contraceptive implant and injectable: These are absorbed through non-oral routes and are not affected by GLP-1's gastrointestinal effects.
• Emergency contraception: If you need emergency contraception while on GLP-1 treatment, consult a healthcare provider or pharmacist. Oral emergency contraceptive pills may theoretically have reduced effectiveness, and a copper IUD for emergency contraception avoids this concern entirely.

The pregnancy warning: why this matters beyond contraception

GLP-1 medications are contraindicated during pregnancy. Weight loss during pregnancy is not recommended and may cause fetal harm. If you are planning to become pregnant, you should discontinue GLP-1 medication before attempting conception — typically at least 1-2 months in advance to allow the medication to clear your system. Unplanned pregnancy while on GLP-1 medication requires immediate discussion with your provider.

Questions to ask your provider

Before starting GLP-1 treatment, have a direct conversation with your provider about contraception. Key questions to discuss include: Is my current contraceptive method compatible with the GLP-1 medication being considered? Should I add a barrier method during the initial weeks of treatment or dose increases? If I am using oral contraceptives, would switching to a non-oral method be advisable? What are my plans for pregnancy, and how does GLP-1 treatment timing fit into those plans?

The bottom line

The interaction between GLP-1 medications and oral contraceptives is manageable — not a reason to avoid treatment if GLP-1 is otherwise appropriate for you. The key is awareness and planning. Know which category your contraceptive falls into, understand the specific guidance for your GLP-1 medication, and have an explicit conversation with your provider about contraception before starting treatment. Do not assume your provider will raise the topic — bring it up yourself. And if pregnancy occurs while on GLP-1 medication, stop the medication immediately and contact your provider.